0000950170-23-045862.txt : 20230831 0000950170-23-045862.hdr.sgml : 20230831 20230831182216 ACCESSION NUMBER: 0000950170-23-045862 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230831 FILED AS OF DATE: 20230831 DATE AS OF CHANGE: 20230831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gruia Gabriela CENTRAL INDEX KEY: 0001860326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 231230197 MAIL ADDRESS: STREET 1: C/O TSCAN THERAPEUTICS, INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 ownership.xml 4 X0508 4 2023-08-31 0001183765 Molecular Templates, Inc. MTEM 0001860326 Gruia Gabriela C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD., SUITE 100 AUSTIN TX 78729 true true false false Interim Chief Medical Officer false Stock Option (right to buy) 8.51 2023-08-31 4 A false 11666 0 A 2033-08-31 Common Stock 11666 11666 D The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023. 25% of the total number of shares subject to the option shall vest on August 31, 2024 and the remaining 75% shall vest in thirty-six (36) equal monthly installments, subject to the reporting person's continued service through the applicable vesting dates. /s/ Gabriela Gruia 2023-08-31